Patent Applications published on Jun 9, 2022 - page 4

#901
US20220175755A1
Human necessities

METHODS OF TREATING TOBACCO SMOKING ADDICTION, AND TREATING NICOTINE AND TOBACCO SMOKING ADDICTION

#902
US20220175756A1
Human necessities

APPLICATION OF COMBINATION OF QUINOLINE DERIVATIVE AND IMMUNOMODULATOR IN PREPARATION OF ANTITUMOR DRUGS

#903
US20220175757A1
Human necessities

Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds

#904
US20220175758A1
Human necessities

COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

#905
US20220175759A1
Human necessities

COMBINED PHARMACEUTICAL COMPOSITION FOR TREATING SMALL CELL LUNG CANCER

#906
US20220175760A1
Human necessities

PHARMACEUTICAL FORMULATIONS

#907
US20220175761A1
Human necessities

BI-LIGAND DRUG CONJUGATE AND USE THEREOF

#908
US20220175762A1
Human necessities

IMMUNE MODULATORY COMPOSITIONS AND METHODS FOR TREATING CANCERS

#909
US20220175763A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNE CHECKPOINT THERAPY

#910
US20220175764A1
Human necessities

USE OF METHYLNALTREXONE AND RIFAXIMIN FOR TREATMENT OF INCREASED GUT PERMEABILITY OR ASSOCIATED DISORDERS

#911
US20220175765A1
Human necessities

ROR-GAMMA MODULATORS

#912
US20220175766A1
Human necessities

COMPOSITIONS AND METHODS OF TREATMENT

#913 ✅ Patent 12,357,629 granted on 2025-07-15
US20220175767A1
Human necessities

Uses of Bcl-2 Antagonists for Treating Cancer and Diagnostics Related Thereto

#914
US20220175768A1
Human necessities

FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF UROTHELIAL CARCINOMA

#915
US20220175769A1
Human necessities

METHOD OF TREATMENT OF ACTINIC KERATOSES

#916
US20220175770A1
Human necessities

TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION

#917
US20220175771A1
Human necessities

CANCER TREATMENT MODALITIES

#918
US20220175772A1
Human necessities

METHODS OF TREATING SJOGREN'S SYNDROME USING A BRUTON'S TYROSINE KINASE INHIBITOR

#919 ✅ Patent 11,872,192 granted on 2024-01-16
US20220175773A1
Human necessities

RET inhibitor for use in treating cancer having a RET alteration

#920
US20220175774A1
Human necessities

Bioavailable Oral Dosage Form Of Tyrosine-Kinase Inhibitor

#921 ✅ Patent 12,011,444 granted on 2024-06-18
US20220175775A1
Human necessities

N-substituted indole derivatives as PGE2 receptor modulators

#922
US20220175776A1
Human necessities

COMBINATION OF CHIR99021 AND VALPROIC ACID FOR TREATING HEARING LOSS

#923
US20220175777A1
Human necessities

Inhibitors of Multidrug Resistance Transporter P-Glycoprotein

#924
US20220175778A1
Human necessities

COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING HER2 EXON 21 INSERTIONS

#925
US20220175779A1
Human necessities

COMPOUNDS AGAINST CANCER BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS

#926 ✅ Patent 12,285,431 granted on 2025-04-29
US20220175780A1
Human necessities

Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors

#927
US20220175781A1
Human necessities

CD40L COMPOSITIONS AND METHODS FOR TUNABLE REGULATION

#928 ✅ Patent 12,083,121 granted on 2024-09-10
US20220175782A1
Human necessities

Substituted piperazines as KRAS G12C inhibitors

#929
US20220175783A1
Human necessities

OSIMERTINIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER

#930
US20220175784A1
Human necessities

ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS

#931
US20220175785A1
Human necessities

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#932
US20220175786A1
Human necessities

PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER

#933
US20220175787A1
Human necessities

PATIENT SELECTION FOR ENHANCEMENT OF ANTI-TUMOR IMMUNITY IN CANCER PATIENTS

#934 ✅ Patent 11,963,963 granted on 2024-04-23
US20220175788A1
Human necessities

6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes

#935 ✅ Patent 11,951,109 granted on 2024-04-09
US20220175789A1
Human necessities

EZH2 inhibitors for treating lymphoma

#936 ✅ Patent 12,194,049 granted on 2025-01-14
US20220175790A1
Human necessities

Composition for treating carbapenem antibiotic-resistant infection

#937
US20220175791A1
Human necessities

Methods for Predicting Neisseria Spp. Susceptibility to Cefixime

#938 ✅ Patent 11,617,755 granted on 2023-04-04
US20220175792A1
Human necessities

Pharmaceutical compositions comprising meloxicam

#939
US20220175793A1
Human necessities

THE USE OF AN MGLUR5 ANTAGONIST FOR TREATING OPIOID ANALGESIC TOLERANCE

#940 ✅ Patent 11,826,371 granted on 2023-11-28
US20220175794A1
Human necessities

Oral formulation of clonidine and midazolam for sedation in dental procedures

#941
US20220175795A1
Human necessities

USE OF FULVESTRANT FOR THE THERAPEUTIC CARE OF CENTRAL CORE DISEASE

#942 ✅ Patent 11,471,469 granted on 2022-10-18
US20220175796A1
Human necessities

Deuterated forms of testosterone and methods of use

#943
US20220175797A1
Human necessities

OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD

#944
US20220175798A1
Human necessities

COMPOSITIONS COMPRISING OXYGENATED CHOLESTEROL SULFATE AND AT LEAST ONE OF POLYALKYLENE GLYCOL, CARBOXYMETHYL CELLULOSE AND POLYOXYLGLYCERIDE

#945
US20220175799A1
Human necessities

COMPOSITIONS HAVING THE ABILITY TO PROMOTE HEALTHY CHOLESTEROL LEVELS

#946
US20220175800A1
Human necessities

DISPERSIBLE TABLET COMPOSITION

#947
US20220175801A1
Human necessities

Combination Therapy For Prostate Cancer

#948
US20220175802A1
Human necessities

COMBINATION OF MINOCYCLINE AND BENZOYL PEROXIDE AND METHOD OF USE THEREOF

#949
US20220175803A1
Human necessities

METHODS OF TREATING CHARCOT-MARIE-TOOTH DISEASE

#950 ✅ Patent 11,865,125 granted on 2024-01-09
US20220175804A1
Human necessities

APKC inhibitors and methods of treating a neurodegenerative disease or disorder

#951 ✅ Patent 11,491,169 granted on 2022-11-08
US20220175805A1
Human necessities

Remdesivir treatment methods

#952
US20220175806A1
Human necessities

PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBERS IN THE TREATMENT OF MUSCLE INJURIES

#953
US20220175807A1
Human necessities

ANTI-VIRAL AND ANTI-TUMORAL COMPOUNDS

#954 ✅ Patent 11,878,026 granted on 2024-01-23
US20220175808A1
Human necessities

Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists

#955
US20220175809A1
Human necessities

TREATMENT AND PREVENTION OF INFECTIONS BY HERPESVIRIDAE WITH DELPHINIDIN-3-GLUCOSIDE

#956
US20220175810A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS

#957
US20220175811A1
Human necessities

STABLE FORMULATIONS OF CYCLIC DINUCLEOTIDE STING AGONIST COMPOUNDS AND METHODS OF USE THEREOF

#958
US20220175812A1
Human necessities

POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY

#959 ✅ Patent 11,491,176 granted on 2022-11-08
US20220175813A1
Human necessities

Methods for treating or preventing ophthalmological conditions

#960
US20220175814A1
Human necessities

IMMUNOTHERAPY FOR THE TREATMENT OF CANCER

#961
US20220175815A1
Human necessities

COMBINATION THERAPIES BASED ON PD1 AND IL-17B INHIBITORS

#962
US20220175816A1
Human necessities

AIM2 INHIBITORS AND USES THEREOF

#963
US20220175817A1
Human necessities

Pharmaceutical Composition for Treating Muscle Disease

#964
US20220175818A1
Human necessities

Inhibition of Monoamine Oxidase Subtype A (MAOA) Mitigates Cardiovascular Calcification

#965
US20220175819A1
Human necessities

DELIVERY AND RETENTION OF ACTIVE AGENTS WITHIN THE SKIN

#966
US20220175820A1
Human necessities

DEXTRAN SULFATE FOR INFLAMMATORY DERMATOSES

#967
US20220175821A1
Human necessities

METHODS FOR IMPROVING ANTI-OXIDATION AND PREVENTING/TREATING DISEASES USING HYPO-ACYLATED LIPOPOLYSACCHARIDE

#968 ✅ Patent 12,251,399 granted on 2025-03-18
US20220175822A1
Human necessities

Inducing caspase activity

#969 ✅ Patent 12,350,289 granted on 2025-07-08
US20220175823A1
Human necessities

POLYMER AGENTS FOR CARDIOPULMONARY RESUSCITATION

#970 ✅ Patent 11,857,566 granted on 2024-01-02
US20220175824A1
Human necessities

Sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu

#971
US20220175825A1
Human necessities

COMPOSITION AND ASSOCIATED DELIVERY DEVICE FOR HYDROGEN THERAPY

#972 ✅ Patent 11,752,170 granted on 2023-09-12
US20220175826A1
Human necessities

Solid preparation, method for producing solid preparation, and method for generating hydrogen

#973
US20220175827A1
Human necessities

Biosynthesis of Selenium Nanoparticles Having Antimicrobial Activity

#974 ✅ Patent 12,251,400 granted on 2025-03-18
US20220175828A1
Human necessities

Liquid concentrates of calcium and magnesium

#975
US20220175829A1
Human necessities

Antimicrobial Compositions

#976
US20220175830A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER

#977
US20220175831A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER

#978 ✅ Patent 12,246,037 granted on 2025-03-11
US20220175832A1
Human necessities

Methods and systems for increased production of stem cells

#979
US20220175833A1
Human necessities

TARGETED DELIVERY OF IMMUNE-MODULATING VHH AND VHH-FUSION PROTEIN

#980
US20220175834A1
Human necessities

METHODS FOR CULTURING IMMUNE CELLS

#981
US20220175835A1
Human necessities

INDUCTION OF INFECTIOUS TOLERANCE BY EX VIVO REPROGRAMMED IMMUNE CELLS

#982
US20220175836A1
Human necessities

PRIMING WITH TARGETED ACTIVATED T CELLS CAN ENHANCE CHEMO RESPONSIVENESS OF CANCER CELLS

#983
US20220175837A1
Human necessities

METHODS FOR PRODUCING REGULATORY B CELLS AND USES THEREOF

#984 ✅ Patent 12,064,450 granted on 2024-08-20
US20220175838A1
Human necessities

Tumoricidal and antimicrobial compositions and methods

#985
US20220175839A1
Human necessities

TARGETED DISRUPTION OF THE MHC CELL RECEPTOR

#986 ✅ Patent 12,359,169 granted on 2025-07-15
US20220175840A1
Human necessities

UNIVERSAL CAR-T CELL AND PREPARATION METHOD AND USE THEREOF

#987
US20220175841A1
Human necessities

The Treatment of Protein Aggregation Diseases

#988
US20220175842A1
Human necessities

EXOSOMES AND USES THEREOF IN DISEASES OF THE BRAIN

#989
US20220175843A1
Human necessities

Treatment of Microvascular Disorders with Mesenchymal Stem Cells and Their Exosomes

#990 ✅ Patent 12,213,996 granted on 2025-02-04
US20220175844A1
Human necessities

Methods of treating optic nerve diseases using neural progenitor cell growth factors

#991 ✅ Patent 12,285,444 granted on 2025-04-29
US20220175845A1
Human necessities

Multicistronic miRNA delivery for cardiac reprogramming

#992
US20220175846A1
Human necessities

METHOD FOR INCREASING PROPORTION OF CD56 POSITIVE CELLS

#993
US20220175847A1
Human necessities

Salivary Gland Cell Sheets and Methods for their Production and Use

#994
US20220175848A1
Human necessities

METHODS AND COMPOSITIONS FOR CELL THERAPY

#995
US20220175849A1
Human necessities

COMPOSITIONS AND METHODS FOR PREVENTING THE PROLIFERATION AND EPITHELIAL-MESENCHYMAL TRANSITION OF EPITHELIAL CELLS

#996
US20220175850A1
Human necessities

COMPOSITIONS AND METHODS FOR CANCER THERAPY

#997
US20220175851A1
Human necessities

COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH

#998 ✅ Patent 12,064,458 granted on 2024-08-20
US20220175852A1
Human necessities

Use of product in treating thermal injury

#999 ✅ Patent 11,491,193 granted on 2022-11-08
US20220175853A1
Human necessities

Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

#1000 ✅ Patent 11,717,544 granted on 2023-08-08
US20220175854A1
Human necessities

Pairing probiotics and prebiotics, methods for growth and use, separately and in combination

#1001 ✅ Patent 12,329,791 granted on 2025-06-17
US20220175855A1
Human necessities

MIXTURE OF PROBIOTIC BACTERIA STRAINS FOR USE IN THE TREATMENT OF ALLERGIC ASTHMA AND WITH RECURRENT WHEEZING, PREFERABLY IN PAEDIATRICT SUBJECTS

#1002
US20220175856A1
Human necessities

UNRAVELING RECEPTOR-METABOLITE INTERACTIONS IN THE HUMAN MICROBIOME

#1003 ✅ Patent 11,992,511 granted on 2024-05-28
US20220175857A1
Human necessities

strain and use thereof

#1004 ✅ Patent 11,819,526 granted on 2023-11-21
US20220175858A1
Human necessities

Lactobacillus Gasseri KBL697 strain and use thereof

#1005
US20220175859A1
Human necessities

Tetraselmis Extract

#1006
US20220175860A1
Human necessities

DUNALIELLA ALGA PREPARATION FOR PREVENTION AND/OR TREATMENT OF A NEURODEGENERATIVE DISEASE, A DISORDER ASSOCIATED WITH PROTEIN MISFOLDING AND COGNITIVE DECLINE

#1007 ✅ Patent 12,171,796 granted on 2024-12-24
US20220175861A1
Human necessities

Hydrogel wound treatment

#1008
US20220175862A1
Human necessities

CO-ADMINISTRATION COMPOSITION FOR PREVENTING OR TREATING HYPERCHOLESTEROLEMIA, CONTAINING BALLOON-FLOWER EXTRACT OR PLATYCODIN D DERIVED THEREFROM AS ACTIVE INGREDIENT

#1009 ✅ Patent 12,233,101 granted on 2025-02-25
US20220175863A1
Human necessities

Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and other diseases or symptoms

#1010
US20220175864A1
Human necessities

USE OF GREEN COFFEE BASED COMPOSITIONS FOR IMPROVING INSULIN PROFILE

#1011
US20220175865A1
Human necessities

TRADITIONAL CHINESE MEDICINE COMPOUND COMPOSITION WITH ANTI-ANXIETY EFFECT AND PREPARATION METHOD AND APPLICATIONS THEREOF

#1012
US20220175866A1
Human necessities

ENZYMATICALLY TREATED CATECHIN PRODUCT WITH INCREASED CONTENTS OF GALLIC ACID, EPICATECHIN, AND EPIGALLOCATECHIN AND METHOD FOR PRODUCING SAME

#1013
US20220175867A1
Human necessities

GRAPE EXTRACT, METHOD FOR PRODUCING GRAPE EXTRACT LIQUID, METHOD FOR PRODUCING EXTRACTED AND PURIFIED PRODUCT OF GRAPE, AND METHOD FOR PRODUCING DRIED PRODUCT OF EXTRACTED AND PURIFIED PRODUCT OF GRAPE

#1014
US20220175868A1
Human necessities

INHIBITION OF SARS-CoV-2 VIRUS BY ARUM PALAESTINUM

#1015
US20220175869A1
Human necessities

FORMULATIONS INHIBITING SARS-CoV-2 VIRUS

#1016
US20220175870A1
Human necessities

Therapeutic Compositions Directed To Host Mirna For The Treatment Of Sars-Cov-2 (Covid-19) Infection

#1017 ✅ Patent 11,925,672 granted on 2024-03-12
US20220175871A1
Human necessities

Peptide having antioxidant activity and composition containing same

#1018
US20220175872A1
Human necessities

THERMOGENIC COMPOSITIONS AND METHODS

#1019 ✅ Patent 12,178,838 granted on 2024-12-31
US20220175873A1
Human necessities

Synthetic neuromodulatory peptides

#1020
US20220175874A1
Human necessities

POLYMERIC NANOPARTICLES AND A PROCESS OF PREPARATION THEREOF

#1021
US20220175875A1
Human necessities

METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES

#1022
US20220175876A1
Human necessities

ANGIO-3 FOR TREATMENT OF RETINAL ANGIOGENIC DISEASES

#1023
US20220175877A1
Human necessities

METHODS AND COMPOSITIONS COMPRISING A C-TERMINAL BAX PEPTIDE

#1024
US20220175878A1
Human necessities

METHOD FOR PREPARING EYE DROPS OF CYCLOSPORIN A

#1025
US20220175879A1
Human necessities

THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA

#1026 ✅ Patent 11,911,438 granted on 2024-02-27
US20220175880A1
Human necessities

Chloride salt of TAT-NR2B9C

#1027
US20220175881A1
Human necessities

METHOD OF TREATING CONDITIONS OF THE EYE WITH AN ANTI-VEGF DARPIN

#1028
US20220175882A1
Human necessities

BETA-CASEIN A2 AND REDUCING OR PREVENTING SYMPTOMS OF LACTOSE INTOLERANCE

#1029 ✅ Patent 11,666,632 granted on 2023-06-06
US20220175883A1
Human necessities

Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist

#1030
US20220175884A1
Human necessities

MODULATION OF WNT SIGNALING IN AUDITORY DISORDERS

#1031
US20220175885A1
Human necessities

TARGETING BIOLOGICAL AGENTS TO MUCOSAL DEFECTS OF THE GASTROINTESTINAL TRACT

#1032
US20220175886A1
Human necessities

NET STABILIZATION AS A THERAPY FOR SEPSIS

#1033
US20220175887A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS USING RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS

#1034
US20220175888A1
Human necessities

CARBOXYLATED OSTEOCALCIN FOR TREATMENT OF AMYLOIDOSIS OR DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING

#1035 ✅ Patent 11,918,627 granted on 2024-03-05
US20220175889A1
Human necessities

Dosage regimen for inhaled vasoactive intestinal polypeptide

#1036
US20220175890A1
Human necessities

THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#1037
US20220175891A1
Human necessities

PHARMACEUTICAL COMBINATIONS COMPRISING INSULIN AND AT LEAST AN AGENT SELECTED FROM MELOXICAM, BROMFENAC SODIUM, ACETYLSALICYLIC ACID, SALICYCLIC ACID AND PARACETAMOL

#1038
US20220175892A1
Human necessities

Pyocyanine Demethylases and related Phenazine Degrading Agents Compositions, Methods and Systems for Interfering with Viability of Bacteria

#1039
US20220175893A1
Human necessities

COMBINATIONS OF TANNASE AND PROBIOTIC FORMULATIONS AND METHODS OF USE FOR IMPROVING TANNIN METABOLISM

#1040 ✅ Patent 12,220,448 granted on 2025-02-11
US20220175894A1
Human necessities

Method of treating pathogenic bacterial infectious diseases

#1041 ✅ Patent 11,813,317 granted on 2023-11-14
US20220175895A1
Human necessities

Method for preventing or treating metabolic disorder

#1042
US20220175896A1
Human necessities

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE BY MUCOSAL VACCINATION WITH FC-COUPLED ANTIGENS

#1043 ✅ Patent 12,286,642 granted on 2025-04-29
US20220175897A1
Human necessities

Chimeric antigen receptors (CARS) that bind osteosarcoma and their use in medicine

#1044 ✅ Patent 12,023,372 granted on 2024-07-02
US20220175898A1
Human necessities

Peptides and T cells for use in immunotherapeutic treatment of various cancers

#1045
US20220175899A1
Human necessities

CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR MUTATED FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR FOR USE IN TREATING CANCER

#1046
US20220175900A1
Human necessities

METHOD FOR PREPARATION OF CANCER/TESTIS ANTIGEN-SPECIFIC T-CELLS

#1047
US20220175901A1
Human necessities

DELIVERY OF BACTERIA-DERIVED OUTER MEMBRANE VESICLES

#1048 ✅ Patent 12,214,027 granted on 2025-02-04
US20220175902A1
Human necessities

Stabilisation of live mollicutes bacteria in a liquid composition

#1049
US20220175903A1
Human necessities

METHOD FOR THE PRODUCTION OF OUTER MEMBRANE VESICLES AND IMMUNOGENIC COMPOSITIONS THEREOF

#1050
US20220175904A1
Human necessities

METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES

#1051 ✅ Patent 11,957,744 granted on 2024-04-16
US20220175905A1
Human necessities

Monovalent vaccine formulation and a method for preparation thereof

#1052
US20220175906A1
Human necessities

ZIKA VIRUS RNA VACCINES

#1053 ✅ Patent 11,806,432 granted on 2023-11-07
US20220175907A1
Human necessities

Compositions, methods and uses for thermally stable multi-targeted antigens

#1054
US20220175908A1
Human necessities

Methods for Inducing a Safe Immune Response Against Polio Virus

#1055
US20220175909A1
Human necessities

INFLUENZA VACCINE COMPOSITION BASED ON NOVEL NUCLEIC ACID

#1056
US20220175910A1
Human necessities

NOVEL INFLUENZA ANTIGENS

#1057 ✅ Patent 12,171,825 granted on 2024-12-24
US20220175911A1
Human necessities

Vaccine against infectious bronchitis

#1058 ✅ Patent 11,771,759 granted on 2023-10-03
US20220175912A1
Human necessities

Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use

#1059 ✅ Patent 11,850,282 granted on 2023-12-26
US20220175913A1
Human necessities

Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same

#1060 ✅ Patent 12,239,706 granted on 2025-03-04
US20220175914A1
Human necessities

Method and system for protecting monarch butterflies from pesticides

#1061 ✅ Patent 11,759,518 granted on 2023-09-19
US20220175915A1
Human necessities

Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

#1062
US20220175916A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CHRONIC EFFECTS OF RADIATION AND CHEMICAL EXPOSURE

#1063
US20220175917A1
Human necessities

COMBINATION OF IAP INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR

#1064
US20220175918A1
Human necessities

COMPOSITIONS AND METHODS FOR MODULATION OF ANTIBODY ACTIVITY

#1065
US20220175919A1
Human necessities

THERAPEUTIC AGENTS FOR PANCREATIC CANCER

#1066
US20220175920A1
Human necessities

RECOMBINANT PROTEINS WITH CD40 ACTIVATING PROPERTIES

#1067
US20220175921A1
Human necessities

ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF

#1068 ✅ Patent 12,296,007 granted on 2025-05-13
US20220175922A1
Human necessities

High concentration anti-blys pharmaceutical formulations

#1069
US20220175923A1
Human necessities

FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES

#1070
US20220175924A1
Human necessities

LIQUID PHARMACEUTICAL COMPOSITION

#1071
US20220175925A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TREATMENT-RESISTANT CANCER

#1072
US20220175926A1
Human necessities

TARGETED SYNERGISTIC CANCER IMMUNOTHERAPY

#1073 ✅ Patent 11,607,456 granted on 2023-03-21
US20220175927A1
Human necessities

Pharmaceutical compositions comprising meloxicam

#1074 ✅ Patent 11,633,480 granted on 2023-04-25
US20220175928A1
Human necessities

Biodegradable lipids for the delivery of active agents

#1075 ✅ Patent 11,590,229 granted on 2023-02-28
US20220175929A1
Human necessities

Biodegradable lipids for the delivery of active agents

#1076 ✅ Patent 11,612,657 granted on 2023-03-28
US20220175930A1
Human necessities

Biodegradable lipids for the delivery of active agents

#1077
US20220175931A1
Human necessities

OSMOTIC PRESSURE REGULATOR FOR PERITONEAL DIALYSATE CONTAINING D-ALLOSE AND/OR D-ALLULOSE

#1078
US20220175932A1
Human necessities

POLYMER SYSTEM FOR OPHTHALMIC DRUG DELIVERY

#1079
US20220175933A1
Human necessities

Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of Glioblastoma

#1080
US20220175934A1
Human necessities

MULTIVALENT LIGAND CLUSTERS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

#1081
US20220175935A1
Human necessities

RNA Aptamers and Uses Thereof

#1082
US20220175936A1
Human necessities

ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF

#1083 ✅ Patent 12,156,915 granted on 2024-12-03
US20220175937A1
Human necessities

Selected artemisinin dimers for the treatment of lashmaniasis

#1084
US20220175938A1
Human necessities

Poly(Beta-Thioester) Polymers and Polymeric Nanoparticles

#1085
US20220175939A1
Human necessities

THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME

#1086
US20220175940A1
Human necessities

PEPTIDE AND USE THEREOF

#1087 ✅ Patent 12,290,569 granted on 2025-05-06
US20220175941A1
Human necessities

Methods and compositions using peptides and proteins with c-terminal elements

#1088
US20220175942A1
Human necessities

EVASINS FOR USE IN THERAPY AND DIAGNOSTICS

#1089
US20220175943A1
Human necessities

VARIANT FC DOMAINS AND USES THEREOF

#1090
US20220175944A1
Human necessities

ANTI-CD117 ANTIBODY-DRUG CONJUGATES AND USES THEREOF

#1091
US20220175945A1
Human necessities

ANTIBODIES AND ENONOMERS

#1092
US20220175946A1
Human necessities

CONDITIONING METHODS FOR GENE THERAPY

#1093 ✅ Patent 11,938,194 granted on 2024-03-26
US20220175947A1
Human necessities

Cysteine mutated antibodies for conjugation

#1094
US20220175948A1
Human necessities

TREATMENT OF CAR T-CELL TOXICITY

#1095
US20220175949A9
Human necessities

PEPTIDES DERIVED FROM TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY M MEMBER 1 (TRPM1), COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES

#1096 ✅ Patent 12,257,340 granted on 2025-03-25
US20220175950A1
Human necessities

Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof

#1097
US20220175951A1
Human necessities

Anti-CD45 Antibody Drug Conjugates and Uses Thereof

#1098
US20220175952A1
Human necessities

TREATING MYELOMAS

#1099
US20220175953A1
Human necessities

BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY

#1100
US20220175954A1
Human necessities

HYPOXIA-INDUCING CRYOGELS

#1101
US20220175955A1
Human necessities

PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE

#1102
US20220175956A1
Human necessities

HAIRPIN-LIKE OLIGONUCLEOTIDE-CONJUGATED SPHERICAL NUCLEIC ACID

#1103
US20220175957A1
Human necessities

DELIVERY OF MACROMOLECULES INTO THE CENTRAL NERVOUS SYSTEM VIA THE BLOODSTREAM

#1104
US20220175958A1
Human necessities

Doxorubicin Containing Nanoplexes and Uses Thereof

#1105 ✅ Patent 12,070,508 granted on 2024-08-27
US20220175959A1
Human necessities

Microparticles and nanoparticles having sulfate groups on the surface

#1106
US20220175960A1
Human necessities

FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE

#1107
US20220175961A1
Human necessities

IMPROVED THERAPEUTIC METHOD FOR RARE OCULAR DISEASES BY GENE REPLACEMENT

#1108
US20220175962A1
Human necessities

GENE THERAPY COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE

#1109 ✅ Patent 11,464,872 granted on 2022-10-11
US20220175963A1
Human necessities

Lentiviral vectors for therapeutic expression of BTK in haematopoietic cells

#1110 ✅ Patent 12,337,040 granted on 2025-06-24
US20220175964A1
Human necessities

DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS

#1111 ✅ Patent 11,779,655 granted on 2023-10-10
US20220175965A1
Human necessities

AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy (ALD) and/or adrenomyeloneuropathy (AMN)

#1112
US20220175966A1
Human necessities

NEW GENE THERAPY CONSTRUCTS

#1113
US20220175967A1
Human necessities

GENE THERAPIES FOR USHER SYNDROME (USH1B)

#1114
US20220175968A1
Human necessities

NON-ACTIVE LIPID NANOPARTICLES WITH NON-VIRAL, CAPSID FREE DNA

#1115
US20220175969A1
Human necessities

ENHANCED HUMAN OPSIN PROMOTER FOR ROD SPECIFIC EXPRESSION

#1116
US20220175970A1
Human necessities

CONTROLLED EXPRESSION OF TRANSGENES USING CLOSED-ENDED DNA (CEDNA) VECTORS

#1117
US20220175971A1
Human necessities

DYE ENHANCED VISUALIZATION OF CATARACT SURGERY

#1118 ✅ Patent 12,239,719 granted on 2025-03-04
US20220175972A1
Human necessities

Fluorochemical targeted therapies

#1119
US20220175973A1
Human necessities

METHOD FOR PRODUCING RADIOPHARMACEUTICAL AND RADIOPHARMACEUTICAL

#1120
US20220175974A1
Human necessities

TARGETING COMPOUNDS FOR CANCERS SELECTED FROM ESOPHAGUS, PHARYNX AND LARYNX, LUNG, BRAIN, AND INTESTINES

#1121 ✅ Patent 12,285,502 granted on 2025-04-29
US20220175975A1
Human necessities

HER3 peptides for imaging and radiotherapy

#1122 ✅ Patent 12,016,936 granted on 2024-06-25
US20220175976A1
Human necessities

Neovascular-targeting contrast medium composition and method for preparing same

#1123
US20220175977A1
Human necessities

COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY

#1124
US20220175978A1
Human necessities

FUNCTIONALIZED SILICA NANORINGS, METHODS OF MAKING SAME, AND USES THEREOF

#1125 ✅ Patent 12,151,035 granted on 2024-11-26
US20220175979A1
Human necessities

Multi sterilization chamber pack

#1126
US20220175980A1
Human necessities

Device and method to inactivate viruses and kill living bacteria

#1127 ✅ Patent 11,717,584 granted on 2023-08-08
US20220175981A1
Human necessities

Supported X-ray horn for controlling e-beams

#1128
US20220175982A1
Human necessities

METHODS AND DEVICES FOR SANITIZATION

#1129
US20220175983A1
Human necessities

Device With A Self-Disinfecting Surface

#1130
US20220175984A1
Human necessities

DISINFECTION DEVICE

#1131 ✅ Patent 11,883,547 granted on 2024-01-30
US20220175985A1
Human necessities

Paper money sanitation apparatus

#1132
US20220175986A1
Human necessities

DECONTAMINATION METHOD

#1133
US20220175987A1
Human necessities

UVC-ENHANCED ELECTROMAGNETIC RADIATION WITH REFLECTIVE SHIELDS AND MATS

#1134
US20220175988A1
Human necessities

PRINTABLE ULTRAVIOLET-C (UV-C) CHAMBER TO DECONTAMINATE REUSABLE PERSONAL PROTECTIVE EQUIPMENT (PPE)

#1135
US20220175989A1
Human necessities

DISINFECTION DEVICE

#1136 ✅ Patent 11,723,997 granted on 2023-08-15
US20220175990A1
Human necessities

UV light disinfection and cleaning of narrow tube lumens

#1137 ✅ Patent 11,707,545 granted on 2023-07-25
US20220175991A1
Human necessities

Light source module and ultraviolet ray irradiating apparatus including the same

#1138 ✅ Patent 12,280,168 granted on 2025-04-22
US20220175992A1
Human necessities

Method for sanitization of a chromatography column

#1139 ✅ Patent 12,220,495 granted on 2025-02-11
US20220175993A1
Human necessities

Mechanical multi-stage connection and disconnection maintaining sterile barrier

#1140 ✅ Patent 12,161,770 granted on 2024-12-10
US20220175994A1
Human necessities

Load volume determination method for a sterilization apparatus

#1141 ✅ Patent 12,171,896 granted on 2024-12-24
US20220175995A1
Human necessities

Hand sanitizing apparatus and method for a vehicle

#1142
US20220175996A1
Human necessities

AUTOCLAVABLE HUMAN INTERFACE DEVICE

#1143 ✅ Patent 11,638,770 granted on 2023-05-02
US20220175997A1
Human necessities

Ultraviolet sanitizing apparatus

#1144 ✅ Patent 11,957,808 granted on 2024-04-16
US20220175998A1
Human necessities

Face mask tree

#1145 ✅ Patent 12,214,100 granted on 2025-02-04
US20220175999A1
Human necessities

Sheet metal handle, and cover with sheet metal handle

#1146
US20220176000A1
Human necessities

DEODORISING COMPOSITION

#1147 ✅ Patent 12,296,072 granted on 2025-05-13
US20220176001A1
Human necessities

Disinfectant fogging composition

#1148
US20220176002A1
Human necessities

DISPENSER FOR DISPENSING VOLATILE COMPOSITIONS

#1149 ✅ Patent 11,752,232 granted on 2023-09-12
US20220176003A1
Human necessities

Personalized forced air purifier

#1150
US20220176004A1
Human necessities

NEBULIZER DISINFECTING SYSTEM AND METHOD OF USE

#1151
US20220176005A1
Human necessities

SYSTEM AND METHOD FOR UVC AIRSTREAM DISINFECTION

#1152
US20220176006A1
Human necessities

WALL-MOUNTED PHOTOCATALYTIC-OXIDIZING AIR PURIFIER

#1153
US20220176007A1
Human necessities

AIR PURIFIER AND PRODUCTION METHOD FOR AIR PURIFIER

#1154
US20220176008A1
Human necessities

Medical Fixing Material with Outstanding Breathability and Ease of Application

#1155 ✅ Patent 11,357,883 granted on 2022-06-14
US20220176009A1
Human necessities

Method for preparing absorbable haemostatic composition for body and haemostatic composition prepared thereby

#1156
US20220176010A1
Human necessities

ABSORBENT ARTICLE

#1157
US20220176011A1
Human necessities

SCAR REDUCING WOUND CLOSURE MATERIALS

#1158 ✅ Patent 11,857,694 granted on 2024-01-02
US20220176012A1
Human necessities

Particles

#1159
US20220176013A1
Human necessities

Compositions and Methods for Application Over Skin

#1160
US20220176014A1
Human necessities

TISSUE REPAIR SCAFFOLD AND DEVICE

#1161 ✅ Patent 12,128,155 granted on 2024-10-29
US20220176015A1
Human necessities

Tissue equivalent tubular scaffold structure, and methods of production thereof

#1162
US20220176016A1
Human necessities

IMPLANT MATERIAL CONTAINING SURFACE-TREATED AROMATIC POLYETHER KETONE AND MANUFACTURING METHOD THEREFOR

#1163 ✅ Patent 12,201,748 granted on 2025-01-21
US20220176017A1
Human necessities

Biopolymer scaffold implants and methods for their production

#1164
US20220176018A1
Human necessities

A PROCESS FOR PREVENTION OF DEGRADATION AND DEGENERATION OF TISSUE USED IN BIOPROSTHESIS

#1165
US20220176019A1
Human necessities

POROUS POLYMER SCAFFOLD AND METHODS THEREOF

#1166
US20220176020A1
Human necessities

Improved Bone Implant Matrix Comprising Proline-Rich Peptide And Method Of Preparing The Same

#1167
US20220176021A1
Human necessities

PLATELET-DERIVED GROWTH FACTOR COMPOSITIONS AND METHODS OF USE THEREOF

#1168
US20220176022A1
Human necessities

MEDICAL DEVICE AND METHOD FOR MANUFACTURING SAME

#1169 ✅ Patent 11,633,532 granted on 2023-04-25
US20220176023A1
Human necessities

Device for promoting wound healing by high polymer low temperature ionized gas

#1170 ✅ Patent 12,318,519 granted on 2025-06-03
US20220176024A1
Human necessities

Oxygenator with pressure relief and sampling

#1171 ✅ Patent 12,005,170 granted on 2024-06-11
US20220176025A1
Human necessities

Priming of spinning membrane separators

#1172
US20220176026A1
Human necessities

FLEXIBLE TUBE ROUTING ACCESSORY FOR PERITONEAL DIALYSIS SYSTEM

#1173
US20220176027A1
Human necessities

Disposable Medical Flow-Regulating Device and System

#1174
US20220176028A1
Human necessities

BLOOD PERFUSION DEVICE

#1175 ✅ Patent 12,042,591 granted on 2024-07-23
US20220176029A1
Human necessities

Blood purification device

#1176
US20220176030A1
Human necessities

SUCTION BAG FOR MEDICAL OR SURGICAL USE, AND SUCTION BAG ARRANGEMENT

#1177 ✅ Patent 12,109,353 granted on 2024-10-08
US20220176031A1
Human necessities

Dynamic pressure response and catheter occlusion system

#1178 ✅ Patent 12,268,805 granted on 2025-04-08
US20220176032A1
Human necessities

Dressing with integrated pump and releasably coupled pump actuator

#1179 ✅ Patent 12,178,993 granted on 2024-12-31
US20220176033A1
Human necessities

Disposable delivery assembly for a drug delivery device

#1180
US20220176034A1
Human necessities

DRUG DISCHARGE ASSEMBLY AND DRUG INJECTION DEVICE COMPRISING SAME

#1181 ✅ Patent 11,911,592 granted on 2024-02-27
US20220176035A1
Human necessities

Safety drip chamber spike with breakable feature

#1182
US20220176036A1
Human necessities

PUMP CASSETTE WITH RADIO FREQUENCY IDENTIFICATION TAG

#1183
US20220176037A1
Human necessities

CONCURRENT INFUSION WITH COMMON LINE AUTO FLUSH

#1184
US20220176038A1
Human necessities

SAFETY SYRINGE

#1185 ✅ Patent 11,944,785 granted on 2024-04-02
US20220176039A1
Human necessities

Healthcare service management via remote monitoring and patient modeling

#1186
US20220176040A1
Human necessities

SYSTEM AND METHOD FOR ADMINISTERING RADIOACTIVE AGENTS TO A SUBJECT

#1187
US20220176041A2
Human necessities

SELF-CONTAINED AUTO-INJECTOR

#1188 ✅ Patent 12,337,150 granted on 2025-06-24
US20220176042A1
Human necessities

AUTO INJECTOR WITH BI-STABLE CLUTCH PLATE

#1189
US20220176043A1
Human necessities

GRIP FOR MOUNTING A CYSTOTOME TO A SYRINGE, AN ASSEMBLY THEREOF, AND A METHOD RELATED THERETO

#1190
US20220176044A1
Human necessities

SYRINGE

#1191 ✅ Patent 12,186,544 granted on 2025-01-07
US20220176045A1
Human necessities

Injection assembly with movable sleeve

#1192 ✅ Patent 12,064,548 granted on 2024-08-20
US20220176046A1
Human necessities

Dynamic output power management for electronic smoking device

#1193 ✅ Patent 11,883,585 granted on 2024-01-30
US20220176047A1
Human necessities

Electronic vapor provision device with absorbent element

#1194 ✅ Patent 11,883,586 granted on 2024-01-30
US20220176048A1
Human necessities

Electronic vapor provision device with absorbent element

#1195
US20220176049A1
Human necessities

RESPIRATORY THERAPY APPARATUS

#1196 ✅ Patent 12,070,551 granted on 2024-08-27
US20220176050A1
Human necessities

Respiratory assistance device and a method of controlling said device

#1197
US20220176051A1
Human necessities

CONTROL OF FLOW AND/OR PRESSURE PROVIDED BY BREATHING APPARATUS

#1198
US20220176052A1
Human necessities

SYSTEM FOR VENTILATION OF A BEING

#1199
US20220176053A1
Human necessities

DEVICE FOR HEATING ENDOTRACHEAL TUBES PREPARATORY TO NASAL INTUBATION

#1200
US20220176054A1
Human necessities

Intubation Shield